PRIMECAP Odyssey Aggressive Growth (M:POAGX)

Add to Watchlists
Create an Alert
51.81 -0.18  -0.35% Sep 21 USD
View Full Chart
M:POAGX Total Returns Chart

M:POAGX Key Stats

M:POAGX Performance

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 1.51% 2.71% 52
3M 2.07% 3.18% 90
6M 0.23% 8.07% 99
YTD 16.87% 13.92% 27
1Y 32.19% 22.17% 7
3Y 21.19% 14.15% 5
5Y 17.81% 11.69% 1
10Y 18.39% 10.90% 1
As of Sept. 21, 2018. Returns for periods of 1 year and above are annualized.

M:POAGX Asset Allocation

Type % Net % Long % Short
Cash 6.05% 6.05% 0.00%
Stock 93.61% 93.61% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.35% 0.35% 0.00%
Other 0.00% 0.00% 0.00%
As of June 30, 2018

M:POAGX Region Exposure

Americas 92.07%
North America 92.07%
Latin America 0.00%
Greater Europe 1.16%
United Kingdom 0.04%
Europe Developed 0.69%
Europe Emerging 0.00%
Africa/Middle East 0.43%
Greater Asia 6.77%
Japan 3.69%
Australasia 0.00%
Asia Developed 0.19%
Asia Emerging 2.88%
Market Classification
% Developed Markets 97.12%
% Emerging Markets 2.88%
As of June 30, 2018. Region breakdown data is calculated by using the long position holdings of the portfolio.

M:POAGX Stock Sector Exposure

Basic Materials 0.10%
Communication Services 1.25%
Consumer Cyclical 11.51%
Consumer Defensive 2.28%
Energy 0.33%
Financial Services 4.10%
Healthcare 35.70%
Industrials 13.23%
Real Estate 0.00%
Technology 31.51%
Utilities 0.00%
As of June 30, 2018

M:POAGX Stock Market Capitalization

Giant 13.01%
Large 28.25%
Medium 36.65%
Small 19.15%
Micro 2.94%
As of June 30, 2018

M:POAGX Stock Style Exposure

Large Cap Value 8.88%
Large Cap Blend 17.97%
Large Cap Growth 14.74%
Mid Cap Value 3.73%
Mid Cap Blend 5.03%
Mid Cap Growth 28.30%
Small Cap Value 1.96%
Small Cap Blend 5.11%
Small Cap Growth 14.27%
As of June 30, 2018
View More Holdings

M:POAGX Top 10 Holdings

Symbol Name % Weight Price % Chg
NKTR Nektar Therapeutics Inc 5.33% 59.00 +0.96%
ABMD Abiomed Inc 5.19% 384.88 +0.76%
SNE Sony Corp ADR 3.46% 57.00 -3.55%
MU Micron Technology Inc 3.20% 44.74 -2.87%
SGEN Seattle Genetics Inc 2.55% 77.76 -1.57%
ALKS Alkermes PLC 2.34% 41.56 +1.09%
UAL United Continental Holdings Inc 2.28% 89.94 +0.92%
SFLY Shutterfly Inc A 2.26% 68.66 -2.90%
BB BlackBerry Ltd 2.06% 10.41 +0.68%
AAL American Airlines Group Inc 2.03% 43.60 +4.08%
As of June 30, 2018
Advertisement

M:POAGX One Page Reports

M:POAGX Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class US Equity
Broad Category Equity
Category Name Mid-Cap Growth
Prospectus Objective Aggressive Growth
Fund Owner Firm Name PRIMECAP Odyssey Funds
Benchmark Index
S&P 500 TR USD
100.0%

M:POAGX Manager Info

Name Tenure
Alfred Mordecai 13.76 yrs
James Marchetti 3.75 yrs
Joel Fried 13.76 yrs
M. Ansari 6.31 yrs
Theo Kolokotrones 13.76 yrs

M:POAGX Net Fund Flows

1M 59.70M
3M 348.59M
6M 489.75M
YTD 607.51M
1Y 562.34M
3Y 268.48M
5Y 1.703B
10Y 3.937B
As of Aug. 31, 2018

M:POAGX Risk Info

Beta (5Y) 1.141
Historical Sharpe (10Y) 1.111
Historical Sortino (All) 1.084
Daily Value at Risk (VaR) 1% (All) 3.63%
Monthly Value at Risk (VaR) 1% (All) 17.25%

M:POAGX Fundamentals

Dividend Yield TTM (9-21-18) 0.00%
SEC Yield --
Weighted Average PE Ratio 15.88
Weighted Average Price to Sales Ratio 2.071
Weighted Average Price to Book Ratio 3.626
Weighted Median ROE 7.70%
Weighted Median ROA 0.22%
Forecasted Dividend Yield 0.44%
Forecasted PE Ratio 17.14
Forecasted Price to Sales Ratio 2.011
Forecasted Price to Book Ratio 3.454
Number of Holdings 160
As of June 30, 2018

M:POAGX Growth Estimates

Forecasted 5 Yr Earnings Growth 13.24%
Forecasted Book Value Growth 5.30%
Forecasted Cash Flow Growth 7.31%
Forecasted Earnings Growth 12.06%
Forecasted Revenue Growth 3.76%
As of June 30, 2018

M:POAGX Comparables

Edit

M:POAGX Attributes

Purchase Details
Open to New Investors No
Open to Existing Investors Yes
Minimum Initial Investment 2000.00 USD
Minimum Subsequent Investment 100.00 USD
Fees
Actual 12B-1 Fee --
Actual Management Fee 0.55%
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
Key Dates
Inception Date 11/1/2004
Termination Date
Last Annual Report Date 10/31/2017
Last Prospectus Date 2/28/2018
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

M:POAGX Excel Add-In Codes

  • Name: =YCI("M:POAGX","name")
  • Broad Asset Class: =YCI("M:POAGX", "broad_asset_class")
  • Broad Category: =YCI("M:POAGX", "broad_category_group")
  • Prospectus Objective: =YCI("M:POAGX", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.